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Synthesis of spirocyclic amines by using dipolar cycloadditions of nitrones 
 
Rungroj Saruengkhanphasit, Darren Collier and Iain Coldham* 
Department of Chemistry, University of Sheffield, Sheffield, S3 7HF, U.K. 
 
Aliphatic ketones containing a chloride and alkene 
were heated with hydroxylamine to promote 
cascade, tandem condensation to oximes, 
cyclization to nitrones and 1,3-dipolar 
cycloaddition to tricyclic isoxazolidines as single 
stereoisomers. Single regioisomers were obtained 
when three atoms linked the ketone and 
dipolarophile to give five-membered rings but 
mixtures resulted with four atoms in the tether 
unless a terminal ester was located on the alkene. 
The NÐO bond in the products could be reduced to 
give spirocyclic amines and diamines. 
 
 
Over the last few years we have reported an efficient method to access polycyclic products by 
using a cascade process involving condensation of an aldehyde and an amine, cyclization of 
the resulting imine with displacement of a halide, and then dipolar cycloaddition.
1Ð5
 This 
chemistry provides rapid access to fused or bridged cyclic amine products and has been 
applied to the preparation of natural products such as aspidospermidine,
1
 quebrachamine,
1
 
myrioxazine A,
2
 crispine A,
3
 and macronecine.
4
 An area that we wanted to explore was the 
use of ketones in place of aldehydes as this should allow access to spirocyclic amine 
products.
6 
Spirocyclic amines are present in several natural products, such as pinnaic acid and 
halichlorine,
7
 and the lepadiformines and cylindricines.
8
 Spirocycles are desirable scaffolds 
for drug discovery due to their 3D conformational structures and rigidity that reduces the loss 
of entropy upon ligandÐprotein binding.
9
 The condensation of an N-alkylhydroxylamine and a 
cyclic ketone for the formation of a nitrone followed by dipolar cycloaddition is known to 
give spirocyclic isoxazolidines.
10,11
 Alternatively, condensation of hydroxylamine with a 
ketone followed by in situ cyclization by conjugate addition gives a cyclic nitrone that can 
undergo cycloaddition to give spirocyclic products;
12,13
 this chemistry has found use for the 
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preparation of alkaloids such as histrionicotoxin.
14
 Our methodology provides an alternative 
cyclization mode by displacement of a halide rather than conjugate addition.
15
 This paper 
describes the simple preparation of functionalized ketones and their efficient cascade 
chemistry to give spirocyclic products. 
We needed access to a variety of ketones to explore the effect on the cascade chemistry of the 
tether length between the carbonyl and the alkyl halide, and between the carbonyl and the 
alkene. These were prepared readily (~50% yield) by addition of Grignard reagents to acid 
chlorides,
16
 however better yields of the ketones 1aÐd were obtained by addition of copper(I) 
bromide as a catalyst (Scheme 1). 
 
 
 
Scheme 1 Preparation of ketones 1aÐd. i, Mg, THF, 72 ¡C, 3 h, then Ð78 ¡C, 10 mol% CuBr, 
then addition of the acid chloride and warm to room temp. over 17 h. 
 
With ready access to the ketones 1aÐd in-hand, we set about testing the condensation, 
cyclization, and dipolar cycloaddition cascade chemistry. Heating the ketone 1a with the 
hydrochloride salt of hydroxylamine and N,N-diisopropylethylamine in toluene gave the 
spirocyclic product 2a in 75% yield as a single regio- and diastereoisomer (Scheme 2). 
Likewise, heating ketone 1b with hydroxylamine gave the product 2b. The reaction likely 
proceeds through condensation of the ketone and hydroxylamine, and displacement of 
chloride to give nitrone 3, followed by dipolar cycloaddition to give the products 2a and 2b.
17
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Scheme 2 Cascade chemistry with the ketones 1aÐb. i, 1.5 equiv. NH2OHáHCl, 
i
Pr2NEt, 
PhMe, 110 ¡C, 17 h, or with added 10 mol% n-Bu4NI and 3.5 h to give 2b, 89%. 
 
Both ketones 1a and 1b reacted quickly with hydroxylamine, as judged by TLC analysis. An 
oxime intermediate could not be observed from ketone 1a, indicating that cyclization with 
displacement of chloride is fast for 5-membered ring formation. However the cyclization was 
slower to give nitrone 3b (m = 2). The efficiency of this process could be improved by 
addition of 10 mol% n-Bu4NI. Cyclization on to the iodide should then be faster to give the 6-
membered ring nitrone, and indeed in the presence of n-Bu4NI as a catalyst the yield of the 
product 2b increased to 89% with a reaction time of only 3.5 h. The oximes from these 
ketones should be formed as a mixture of E and Z isomers, yet only one of these (the E-
isomer assigning the haloalkyl chain as a higher priority) can undergo ready cyclization to 
displace the halide. The high yields in the process indicate that the undesired Z-isomer can 
isomerise to the E-isomer. 
The cascade chemistry with ketones 1a and 1b provided a single regioisomer of the products 
2a and 2b (Scheme 2). In contrast, the homologues 1c and 1d, with the extra methylene unit 
between the ketone and the alkene dipolarophile, gave a mixture of regiosiomeric products 
(Scheme 3). 
 
 
 
Scheme 3 Cascade chemistry with the ketones 1cÐd. i, for 1c, 1.5 equiv. NH2OHáHCl, 
i
Pr2NEt, xylene, 140 ¡C, 48 h; ii, for 1d, 1.5 equiv. NH2OHáHCl, 
i
Pr2NEt, 10 mol% n-Bu4NI, 
xylene, 140 ¡C, 24 h. 
 
O
Cl
1c
i or ii
1.3 : 1
N
O
H
2c
m
m
m = 1
1d
1.2 : 1 2d
m = 2
N
O
H
+
63% 4c
70% 4d
m
We found that, in the absence of n-Bu4NI, the ketone 1d gave predominantly the oxime with 
only a small amount of the mixture of regioisomeric cycloaddition products. The 
regioisomeric cycloadducts were inseparable but each was a single stereoisomer as expected 
due to the constrained tricyclic ring structures. 
The cycloadducts 2aÐb were heated with zinc and acetic acid to reduce the NÐO bond to give 
the amino-alcohol products 5a and 5b (Scheme 4). Likewise, the mixture of 2c+4c (and of 
2d+4d) gave the amino-alcohols 5c and 6c (and 5d and 6d) which were separable thereby 
providing single isomers of the desired products (Scheme 5). Single crystal X-ray analysis 
confirmed the structure and relative stereochemistry of the amino-alcohol 5d (formed from 
the cycloadduct 2d). 
 
 
 
Scheme 4 Formation of amino-alcohols 5aÐb.  
 
 
Scheme 5 Formation of amino-alcohols 5cÐd and 6cÐd.  
 
To influence the regiochemistry of the cycloaddition, we opted to install an electron-
withdrawing group at the terminus of the alkene dipolarophile.
13,18
 Cross metathesis with 
methyl acrylate gave the ketones 7c and 7d (Scheme 6). Subsequent treatment of these 
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ketones with hydroxylamine promoted nitrone formation and cycloaddition and we were 
pleased to find that a single regioisomer (and stereoisomer) was produced in each case. A 
possible arrangement for the cycloaddition, which explains the stereochemical outcome and 
matches that proposed in related work by Grigg and co-workers,
13
 is shown in Scheme 6. 
 
 
 
Scheme 6 Cascade chemistry with the ketones 7cÐd. i, methyl acrylate, 3 mol% GrubbsII, 
CH2Cl2, 42 ¡C, 22 h; ii, for 7c, 2.2 equiv. NH2OHáHCl, 
i
Pr2NEt, PhMe, 110 ¡C, 16 h; iii, for 
7d, 2.2 equiv. NH2OHáHCl, 
i
Pr2NEt, 10 mol% n-Bu4NI, PhMe, 110 ¡C, 16 h. 
 
Treating the cycloadducts 8c and 8d with zinc and acetic acid reduced the NÐO bond and 
promoted cyclization of the resulting secondary amine with the ester to give the lactam 
products 9c and 9d (Scheme 7). Single crystal X-ray analysis confirmed the structure and 
relative stereochemistry of the lactam 9d. 
 
 
Scheme 7 Formation of lactams 9cÐd.  
 
The methodology described above provides good yields of spirocyclic amines from acyclic 
ketones. To enhance the attractiveness of this approach from a medicinal chemistry 
perspective, we wanted to decrease the lipophilicity of the compounds and incorporate a 
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further handle for functionalization. This could be achieved by having a heteroatom in the 
chain in place of one of the methylene units. 
Initially we chose the ketone 11 for these studies and this was prepared in two steps from the 
ketone 10 by regioselective bromination,
19
 followed by reaction with diallylamine (Scheme 
8). Heating the ketone 11 with the hydrochloride salt of hydroxylamine and N,N-
diisopropylethylamine in toluene gave only a low yield (20%) of the tricyclic product 12 and 
it was apparent that the ketone 11 was unstable at high temperatures. The presence of an 
amino group within the molecule prompted us to explore the cascade chemistry in the absence 
of added N,N-diisopropylethylamine and we were pleased to find that this allowed the 
formation of the desired product 12 in improved yield (41%). The low yields are likely a 
result of the amino group in the chain reacting with the alkyl chloride. It was possible to 
reduce the NÐO bond of the cycloadduct 12 to provide the amino-alcohol product 13. 
 
 
 
Scheme 8  Cascade chemistry with the ketone 11.  
 
To improve this chemistry, we treated the amine 11 with benzyl chloroformate to displace 
one of the allyl groups to give the carbamate 14 (Scheme 9). This substrate was better 
behaved in the cascade chemistry and led to the formation of tricyclic product 15 in high yield 
as a single isomer. This product was converted to the amino-alcohol 16 by reduction of the 
NÐO bond. 
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Scheme 9  Cascade chemistry with the ketone 14.  
 
To further exemplify this chemistry, the ketone 19 was prepared, starting with the known 
bromide 17 (Scheme 10).
20
 Addition of diallylamine gave the ketone 18 (which did not 
undergo the cascade chemistry and gave a complex mixture on heating with NH2OHáHCl). 
Conversion of the ketone 18 to the ketone 19 was carried out with methyl chloroformate. 
 
 
Scheme 10  Cascade chemistry with the ketone 19.  
 
As expected based on our earlier work (Scheme 3), heating the ketone 19 with the 
hydrochloride salt of hydroxylamine and N,N-diisopropylethylamine gave a mixture of the 
regioisomeric products 20 and 21. These were inseparable and the ratio of isomers was not 
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apparent from the NMR spectra due to the presence of rotamers. However, reduction with 
LiAlH4 gave the amines 22 and 23 and allowed the deduction that the major isomer had the 7-
membered ring (
13
C NMR spectroscopy in CDCl3 showed a CH at 79.1 ppm for the major 
isomer and a CH2 at 70.0 ppm for the minor isomer, corresponding to the carbon attached to 
the oxygen atom). 
Hence we have shown in this work that ketones are suitable substrates for a cascade of 
reactions involving condensation with hydroxylamine, cyclization with halide displacement to 
give a nitrone, and intramolecular dipolar cycloaddition to give tricyclic products. The NÐO 
bond in the product can be reduced to give spirocyclic amines with a variety of ring sizes and 
substitution. The compounds prepared by this chemistry could find application as scaffolds 
for drug discovery. 
 
EXPERIMENTAL SECTION 
All reagents were obtained from commercial suppliers and were used without further 
purification unless otherwise specified. Petrol refers to petroleum ether (b.p. 40Ð60 ¡C). 
Reactions were carried out under nitrogen using oven-dried glassware. Thin layer 
chromatography was performed on silica plates and visualised by UV irradiation at 254 nm or 
by staining with an alkaline KMnO4 dip. Column chromatography was performed using silica 
gel (40Ð63 micron mesh). 
1
H NMR spectra chemical shifts are reported in ppm with respect 
to the residual solvent peaks, with multiplicities given as s = singlet, d = doublet, t = triplet, q 
= quartet, m = multiplet. Coupling constants, J, are quoted to the nearest 0.5 Hz. High 
resolution (accurate mass) mass spectra (HRMS) used electrospray ionisation (ESI) with a 
time-of-flight (TOF) mass analyzer. 
1-Chloronon-8-en-4-one 1a. To a suspension of magnesium (0.11 g, 4.43 mmol) in THF (8 
mL) at room temp., was added 5-bromo-1-pentene (0.50 mL, 4.22 mmol) slowly, and the 
mixture was heated to 72 ¡C. After 3 h, the mixture was allowed to cool to room temp. The 
mixture was cooled to Ð78 ¡C followed by adding copper bromide (0.06 g, 0.42 mmol). After 
10 min, 4-chlorobutyryl chloride (0.50 mL, 4.22 mmol) was added and the mixture was 
allowed to warm to room temp. over 17 h. The mixture was diluted with saturated aqueous 
ammonium chloride (5 mL) and was extracted with Et2O (3 × 10 mL). The combined organic 
layers were dried (MgSO4), filtered, and the solvent was evaporated. Purification by flash 
column chromatography, eluting with EtOAcÐpetrol (0.8:99.2 to 2:98), gave the ketone 1a 
(0.57 g, 3.26 mmol, 77%) as an oil; νmax/cm
-1
 3075, 2935, 1715, 1640; Rf 0.6 [EtOAcÐpetrol 
(1:19)]; 
1
H NMR (400 MHz, CDCl3) δ = 5.84Ð5.74 (1H, m), 5.06Ð4.99 (2H, m), 3.60 (2H, t, J 
7.0 Hz), 2.63 (2H, t, J 7.0 Hz), 2.46 (2H, t, J 7.0 Hz), 2.11Ð2.03 (4H, m), 1.72 (2H, quin, J 
7.0 Hz); 
13
C NMR (101 MHz, CDCl3) δ = 209.6, 137.9, 115.3, 44.5, 42.0, 39.3, 33.0, 26.3, 
22.8; HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C9H16O
35
Cl 175.0890; Found 175.0885; 
LRMS m/z (ES) 177 (30%, MH
+
 for 
37
Cl), 175 (100%, MH
+ 
for 
35
Cl).  
1-Chlorodec-9-en-5-one 1b.
16 
To a suspension of magnesium (0.11 g, 4.43 mmol) in THF (8 
mL) at room temp., was added 5-bromo-1-pentene (0.50 mL, 4.22 mmol) slowly, and the 
mixture was heated to 72 ¡C. After 3 h, the mixture was allowed to cool to room temp. The 
mixture was cooled to Ð78 ¡C followed by adding copper bromide (0.06 g, 0.42 mmol). After 
10 min, 5-chlorovaleroyl chloride (0.55 mL, 4.22 mmol) was added and the mixture was 
allowed to warm to room temp. over 17 h. The mixture was diluted with saturated aqueous 
ammonium chloride (5 mL) and was extracted with Et2O (3 × 10 mL). The combined organic 
layers were dried (MgSO4), filtered, and the solvent was evaporated. Purification by flash 
column chromatography, eluting with EtOAcÐpetrol (1:99 to 2:98), gave the ketone 1b (0.61 
g, 3.25 mmol, 77%) as an oil; νmax/cm
-1
 3080, 2935, 1710, 1645; Rf 0.6 [EtOAcÐpetrol 
(1:19)]; 
1
H NMR (400 MHz, CDCl3) δ = 5.84Ð5.73 (1H, m), 5.06Ð4.98 (2H, m), 3.55 (2H, t, J 
7.0 Hz), 2.46 (2H, t, J 7.0 Hz), 2.43 (2H, t, J 7.0 Hz), 2.11Ð2.05 (2H, m), 1.83Ð1.67 (6H, m); 
13
C NMR (101 MHz, CDCl3) δ = 210.2, 137.9, 115.2, 44.6, 41.8, 41.7, 33.1, 31.9, 22.7, 21.0; 
HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C10H18O
35
Cl 189.1046; Found 189.1047;  LRMS 
m/z (ES) 191 (30%, MH
+
 for 
37
Cl), 189 (100%, MH
+ 
for 
35
Cl). 
1-Chlorodec-9-en-4-one 1c. To a suspension of magnesium (0.20 g, 8.23 mmol) in THF (16 
mL) at room temp., was added 6-bromo-1-hexene (1.0 mL, 7.5 mmol) slowly, and the 
mixture was heated to 72 ¡C. After 3 h, the mixture was allowed to cool to room temp. The 
mixture was cooled to Ð78 ¡C followed by adding copper bromide (0.11 g, 0.75 mmol). After 
10 min, 4-chlorobutyryl chloride (0.85 mL, 7.5 mmol) was added and the mixture was 
allowed to warm to room temp. over 17 h. The mixture was diluted with saturated aqueous 
ammonium chloride (5 mL) and was extracted with Et2O (3 × 10 mL). The combined organic 
layers were dried (MgSO4), filtered, and the solvent was evaporated. Purification by flash 
column chromatography, eluting with EtOAcÐpetrol (0.5:99.5 to 2:98), gave the ketone 1c 
(1.20 g, 6.36 mmol, 85%) as an oil; νmax/cm
-1
 3080, 2930, 1715, 1640; Rf 0.6 [EtOAcÐpetrol 
(1:19)]; 
1
H NMR (400 MHz, CDCl3) δ = 5.83Ð5.76 (1H, m), 5.06Ð4.96 (2H, m), 4.30 (2H, t, J 
7.0 Hz), 2.63 (2H, t, J 7.0 Hz), 2.45 (2H, t, J 7.0 Hz), 2.11Ð2.03 (4H, m), 1.66Ð1.60 (2H, m), 
1.45Ð1.37 (2H, m); 
13
C NMR (101 MHz, CDCl3) δ = 209.8, 138.4, 114.7, 44.5, 42.8, 39.2, 
33.5, 28.4, 26.3, 23.3; HRMS (ESI-TOF) m/z: [M]
+
 Calcd for C10H17O
35
Cl 188.0962; Found 
188.0968; LRMS m/z (ES) 190 (30%, M
+
 for 
37
Cl), 188 (100%, M
+ 
for 
35
Cl). 
1-Chloroundec-10-en-5one 1d.
16
 To a suspension of magnesium (0.19 g, 7.85 mmol) in THF 
(15 mL) at room temp., was added 6-bromo-1-hexene (1.0 mL, 7.5 mmol) slowly, and the 
mixture was heated to 72 ¡C. After 3 h, the mixture was allowed to cool to room temp. The 
mixture was cooled to Ð78 ¡C followed by adding copper bromide (0.11 g, 0.75 mmol). After 
10 min, 5-chlorovaleroyl chloride (1.0 mL, 7.5 mmol) was added and the mixture was 
allowed to warm to room temp. over 17 h. The mixture was diluted with saturated aqueous 
ammonium chloride (5 mL) and was extracted with Et2O (3 × 10 mL). The combined organic 
layers were dried (MgSO4), filtered, and the solvent was evaporated. Purification by flash 
column chromatography, eluting with EtOAcÐpetrol (0.5:99.5 to 2:98), gave the ketone 1b 
(1.14 g, 5.62 mmol, 75%) as an oil; νmax/cm
-1
 3075, 2940, 1715, 1640; Rf 0.6 [EtOAcÐpetrol 
(1:19)]; 
1
H NMR (400 MHz, CDCl3) δ = 5.86Ð5.76 (1H, m), 5.05Ð4.96 (2H, m), 3.56 (2H, t, J 
7.0 Hz), 2.46 (2H, t, J 7.0 Hz), 2.43 (2H, t, J 7.0 Hz), 2.11Ð2.05 (2H, m), 1.83Ð1.70 (4H, m), 
1.65Ð1.50 (2H, m), 1.44Ð1.37 (2H, m); 
13
C NMR (101 MHz, CDCl3) δ = 210.4, 138.4, 114.6, 
44.6, 42.6, 41.7, 33.5, 31.9, 28.4, 23.2, 21.0; HRMS (ESI-TOF) m/z: [M]
+
 Calcd for 
C11H19O
35
Cl 202.1119; Found 202.1120; LRMS m/z (ES) 204 (30%, M
+
 for 
37
Cl), 202 (100%, 
M
+ 
for 
35
Cl). 
(1RS,8RS)-6-Oxa-5-azatricyclo[6.3.0.0
1,5
]undecane 2a. To ketone 1a (219 mg, 1.25 mmol) in 
toluene (15 mL) was added hydroxylamine hydrochloride (104 mg, 1.5 mmol) and 
diisopropylethylamine (0.55 mL, 3.0 mmol) and the mixture was heated to 110 ¡C. After 17 
h, the mixture was allowed to cool to room temp. and the solvent was evaporated. Purification 
by flash column chromatography, eluting with MeOHÐCH2Cl2 (1:99 to 2:98), gave the 
cycloadduct 2a (144 mg, 0.94 mmol, 75%) as an oil; νmax/cm
-1
 2945, 2865, 1440; Rf 0.5 
[MeOHÐCH2Cl2 (5:95)]; 
1
H NMR (400 MHz, CDCl3) δ = 4.08 (1H, br t, J 8.5 Hz), 3.41 (1H, 
dd, J 8.5, 6.5 Hz), 3.33Ð3.27 (1H, m) 3.00Ð2.93 (1H, m), 2.66Ð2.61 (1H, m), 2.04Ð1.96 (2H, 
m), 1.92Ð1.87 (1H, m), 1.84Ð1.65 (5H, m), 1.60Ð1.56 (1H, m), 1.53Ð1.45 (1H, m); 
13
C NMR 
(101 MHz, CDCl3) δ = 83.5, 72.3, 56.2, 56.0, 39.8, 37.9, 31.2, 25.4, 24.9; HRMS (ESI-TOF) 
m/z: [M + H]
+
 Calcd for C9H16NO 154.1232; Found 154.1232; LRMS m/z (ES) 154 (100%, 
MH
+
). 
(1RS,5RS)-7-Oxa-8-azatricyclo[6.4.0.0
1,5
]dodecane 2b.
17
 To ketone 1b (265 mg, 1.41 mmol) 
in toluene (15 mL) was added hydroxylamine hydrochloride (118 mg, 1.69 mmol) and 
diisopropylethylamine (0.60 mL, 3.38 mmol, 3.0 equiv) and the mixture was heated to 110 
¡C. After 17 h, the mixture was allowed to cool to room temp. and the solvent was 
evaporated. Purification by flash column chromatography, eluting with MeOHÐCH2Cl2 (1:99 
to 2:98), gave the cycloadduct 2b (166 mg, 0.99 mmol, 70%) as an oil. 
Alternatively, 
To ketone 1b (362 mg, 1.92 mmol) in toluene (20 mL) was added hydroxylamine 
hydrochloride (200 mg, 2.88 mmol), diisopropylethylamine (1.0 mL, 5.76 mmol) and tetra-n-
butylammonium iodide (71 mg, 0.19 mmol) and the mixture was heated to 110 ¡C. After 2 h, 
the mixture was allowed to cool to room temp. and the solvent was evaporated. Purification 
by flash column chromatography, eluting with MeOHÐCH2Cl2 (1:99 to 2:98), gave the 
cycloadduct 2b (286 mg, 1.71 mmol, 89%) as an oil; Rf 0.5 [MeOHÐCH2Cl2 (5:95)]; 
1
H NMR 
(400 MHz, CDCl3) δ = 4.31 (1H, br t, J 8.5 Hz) 3.48 (1H, dd, J 8.5, 5.0 Hz), 3.05Ð3.14 (1H, 
br m), 2.91Ð2.86 (1H, m), 2.66Ð2.61 (1H, m), 1.97Ð1.60 (8H, m), 1.56Ð1.41 (4H, m); 
13
C 
NMR (101 MHz, CDCl3) δ = 75.2, 72.2, 50.4, 50.0, 39.2, 33.1, 31.3, 24.1, 22.9, 21.5. Data 
consistent with that in the literature.
17
 
(1RS,8RS)-6-Oxa-5-azatricyclo[6.4.0.0
1,5
]dodecane 2c and (1RS,7RS)-6-Oxa-5-
azatricyclo[5.4.1.0
1,5
]dodecane 4c. To ketone 1c (396 mg, 2.10 mmol) in xylene (21 mL) was 
added hydroxylamine hydrochloride (219 mg, 3.15 mmol) and diisopropylethylamine (1.10 
mL, 6.30 mmol) and the mixture was heated to 140 
o
C. After 48 h, the mixture was allowed to 
cool to room temp. and the solvent was evaporated. Purification by flash column 
chromatography, eluting with MeOHÐCH2Cl2 (1:99 to 2:98), gave the cycloadducts 2c and 4c 
(220 mg, 1.32 mmol, 63%) as an inseparable mixture (1:1.3) as an oil; νmax/cm
-1 
2915, 2850, 
1445; Rf 0.5 [MeOHÐCH2Cl2 (5:95)]; 
1
H NMR (400 MHz, CDCl3) δ = 4.39Ð4.35 (0.57H, m), 
3.71 (0.43H, dd, J 7.0, 5.5 Hz), 3.42 (0.43H, dd, J 7.0, 3.0 Hz), 3.34 (0.43H, ddd, J 12.0, 7.0, 
3.0 Hz), 3.11Ð2.98 (1.14H, m), 2.88Ð2.81 (0.43H, m), 2.03Ð1.91 (1.14H, m), 1.87Ð1.75 
(1.14H, m), 1.74Ð1.50 (4.29H, m), 1.48Ð1.02 (7H, m); 
13
C NMR (101 MHz, CDCl3) δ = 78.6, 
73.2, 72.9, 72.5, 57.5, 56.9, 48.5, 41.0, 40.1, 38.5, 36.6, 34.5, 34.3, 27.2, 24.2, 24.1, 23.5, 
23.3, 22.6, 21.7; HRMS (ESI-TOF) m/z: [M]
+
 Calcd for C10H17NO 167.1305; Found 
167.1313; LRMS m/z (ES) 167 (100%, M
+
). 
(1RS,9RS)-7-Oxa-6-azatricyclo[7.4.0.0
1,6
]tridecane 2d and (1RS,8RS)-7-Oxa-6-
azatricyclo[6.4.1.0
1,6
]tridecane 4d. To ketone 1d (751 mg, 3.71 mmol) in toluene (37 mL) 
was added hydroxylamine hydrochloride (387 mg, 5.57 mmol), diisopropylethylamine (2.0 
mL, 11.1 mmol) and tetra-n-butylammonium iodide (137 mg, 0.37 mmol) and the mixture 
was heated to 140 
o
C. After 24 h, the mixture was allowed to cool to room temp. and the 
solvent was evaporated. Purification by flash column chromatography, eluting with MeOHÐ
CH2Cl2 (0.5:99.5 to 2:98), gave the cycloadducts 2d and 4d (474 mg, 2.62 mmol, 71%) as an 
inseparable mixture (1:1.2) as an oil; νmax/cm
-1
 2940, 2850, 1445; Rf 0.5 [MeOHÐCH2Cl2 
(5:95)]; 
1
H NMR (400 MHz, CDCl3) δ = 4.74 (0.55H, br d, J 8.0 Hz), 4.27 (0.45H, dd, J 10.0, 
7.5 Hz), 3.76 (0.45H, br t, J 8.0 Hz), 3.21Ð3.17 (0.55H, m), 3.14Ð3.09 (0.45H, m), 2.85Ð2.76 
(0.9H, m), 2.63Ð2.57 (0.55H, m), 2.55Ð2.49 (0.55H, m), 2.19Ð2.15 (0.45H, m), 2.03Ð1.59 
(8H, m), 1.58Ð1.26 (6.1H, m); 
13
C NMR (101 MHz, CDCl3) δ = 77.4, 69.1, 65.3, 63.0, 53.0, 
50.2, 45.8, 38.8, 35.6, 33.8, 33.7, 31.2, 30.7, 24.7, 24.6, 24.4, 23.5, 23.2, 22.0, 20.9, 19.8, 
19.6; HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C11H20NO 182.1539; Found 182.1537; 
LRMS m/z (ES) 182 (100%, MH
+
). 
(5RS,6RS)-1-Azaspiro[4.4]nonan-6-ylmethanol 5a. Zinc powder (462 mg, 7.06 mmol) was 
added to cycloadduct 2a (256 mg, 1.68 mmol) in AcOH/H2O (9 mL, 1:2), and the mixture 
was heated to 70 ¡C. After 2 h, before being allowed to cool to room temp., the zinc salts 
were filtered, washing the filtrate with CH2Cl2 (20 mL), and the solvent was evaporated. The 
residue was partitioned between aqueous ammonia (18 M, 10 mL) and CH2Cl2 (20 mL) and 
was separated. The aqueous layer was extracted with CH2Cl2 (3 × 20 mL), and the combined 
organic layers were dried (MgSO4), filtered, and the solvent was evaporated to give the 
alcohol 5a (244 mg, 1.57 mmol, 93%) as an oil; νmax/cm
-1
 3295, 2950, 1440; Rf 0.3 [MeOHÐ
CH2Cl2 (5:95)]; 
1
H NMR (400 MHz, CDCl3) δ = 3.68Ð3.63 (2H, m), 3.05Ð3.00 (1H, m), 
2.91Ð2.85 (1H, m), 1.89Ð1.82 (1H, m), 1.78Ð1.56 (9H, m), 1.53Ð1.48 (1H, m); 
13
C NMR (101 
MHz, CDCl3) δ = 72.5, 64.4, 47.0, 46.3, 39.3, 38.7, 26.3, 26.1, 21.9; HRMS (ESI-TOF) m/z: 
[M + H]
+
 Calcd for C9H18NO 156.1383; Found 156.1381; LRMS m/z (ES) 156 (100%, MH
+
). 
(1RS,5RS)-6-Azaspiro[4.5]decan-1-ylmethanol 5b.
17a
 Zinc powder (275 mg, 4.2 mmol) was 
added to cycloadduct 2b (167 mg, 1 mmol) in AcOH/H2O (5 mL, 1:2), and the mixture was 
heated to 70 ¡C. After 2 h, before being allowed to cool to room temp., the zinc salts were 
filtered, washing the filtrate with CH2Cl2 (20 mL), and the solvent was evaporated. The 
residue was partitioned between aqueous ammonia (18 M, 8 mL) and CH2Cl2 (20 mL) and 
was separated. The aqueous layer was extracted with CH2Cl2 (3 × 15 mL), and the combined 
organic layers were dried (MgSO4), filtered, and the solvent was evaporated to give the amino 
alcohol 5b (155 mg, 0.92 mmol, 92%) as an amorphous solid; m.p. 82Ð84 ¡C, lit.
17a
 m.p. for 
5b 84 ¡C; Rf 0.3 [MeOHÐCH2Cl2 (5:95)]; 
1
H NMR (400 MHz, CDCl3) δ = 3.88 (1H, dd, J 
11.5, 4.0 Hz), 3.64 (1H, dd, J 11.5, 6.5 Hz), 2.91Ð2.87 (1H, m), 2.77 (1H, dt, J 11.5, 3.0 Hz), 
1.87Ð1.66 (7H, m), 1.64Ð1.38 (6H, m); 
13
C NMR (101 MHz, CDCl3) δ = 63.7, 63.5, 49.6, 
42.2, 37.1, 35.6, 26.9, 26.3, 22.4, 22.3. Data consistent with that in the literature.
17a
 
(5S,6S)-1-Azaspiro[4.5]decan-6-ylmethanol 5c and (5RS,7RS)-1-Azaspiro[4.6]undecan-7-ol 
6c. Zinc powder (319 mg, 4.87 mmol) was added to the 1:1.3 mixture of cycloadducts 2c and 
4c (195 mg, 1.16 mmol) in AcOH/H2O (6 mL, 1:2), and the mixture was heated to 70 ¡C. 
After 2 h, before being allowed to cool to room temp., the zinc salts were filtered, washing 
the filtrate with CH2Cl2 (20 mL), and the solvent was evaporated. The residue was partitioned 
between aqueous ammonia (18 M, 10 mL) and CH2Cl2 (20 mL) and was separated. The 
aqueous layer was extracted with CH2Cl2 (3 × 15 mL), and the combined organic layers were 
dried (MgSO4), filtered, and the solvent was evaporated. Purification by flash column 
chromatography, eluting with conc. NH3ÐMeOHÐCH2Cl2 (1:9:90), gave the alcohol 5c (68 
mg, 0.40 mmol, 34%) as an oil and the alcohol 6c (86 mg, 0.51 mmol, 44%) as an oil. 
Data for alcohol 5c νmax/cm
-1
 3280, 2920, 1450; Rf 0.5 [conc. NH3ÐMeOHÐCH2Cl2 (1:9:90)]; 
1
H NMR (400 MHz, CDCl3) δ = 3.89Ð3.80 (2H, m), 2.99Ð2.93 (2H, m), 1.99Ð1.95 (2H, m), 
1.83Ð1.66 (3H, m), 1.63Ð1.52 (7H, m), 1.40Ð1.28 (3H, m); 
13
C NMR (101 MHz, CDCl3) δ = 
65.2, 65.0, 45.2, 43.1, 37.3, 36.0, 27.0, 25.7, 23.9, 23.4; HRMS (ESI-TOF) m/z: [M + H]
+
 
Calcd for C10H20NO 170.1539; Found 170.1540; LRMS m/z (ES) 170 (100%, MH
+
). 
Data for alcohol 6c νmax/cm
-1
 3380, 2930, 1450; Rf 0.2 [conc. NH3ÐMeOHÐCH2Cl2 (1:9:90)]; 
1
H NMR (400 MHz, CDCl3) δ = 4.11Ð4.06 (1H, m), 3.10Ð2.97 (4H, m), 2.03 (1H, dd, J 14.5, 
6.5 Hz), 1.91Ð1.73 (7H, m), 1.70Ð1.50 (6H, m); 
13
C NMR (101 MHz, CDCl3) δ = 69.5, 65.9, 
45.6, 44.1, 41.2, 41.0, 37.3, 25.0, 24.3, 24.2; HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for 
C10H20NO 170.1539; Found 170.1540; LRMS m/z (ES) 170 (100%, MH
+
). 
(6RS,7RS)-1-Azaspiro[5.5]undecan-7-ylmethanol 5d and (6RS,8RS)-1-
Azaspiro[5.6]dodecan-8-ol 6d. Zinc powder (453 mg, 6.93 mmol) was added to the 1:1.2 
mixture of cycloadducts 2d and 4d (299 mg, 1.65 mmol) in AcOH/H2O (9 mL, 1:2), and the 
mixture was heated to 70 ¡C. After 2 h, before being allowed to cool to room temp., the zinc 
salts were filtered, washing the filtrate with CH2Cl2 (20 mL), and the solvent was evaporated. 
The residue was partitioned between aqueous ammonia (18 M, 10 mL) and CH2Cl2 (20 mL) 
and was separated. The aqueous layer was extracted with CH2Cl2 (3 × 15 mL), and the 
combined organic layers were dried (MgSO4), filtered, and the solvent was evaporated. 
Purification by flash column chromatography, eluting with conc. NH3ÐMeOHÐCH2Cl2 
(1:9:90), gave the alcohol 5d (125 mg, 0.68 mmol, 41%) as an amorphous solid and the 
alcohol 6d (164 mg, 0.89 mmol, 54%) as an amorphous solid. 
Data for alcohol 5d m.p. 56Ð58 ¡C; νmax/cm
-1
 3275, 2920, 1435; Rf 0.6 [conc. NH3ÐMeOHÐ
CH2Cl2 (1:9:90)]; 
1
H NMR (400 MHz, CDCl3) δ = 4.33 (1H, dd, J 11.0, 3.0 Hz), 3.47 (1H, 
dd, J 11.0, 3.0 Hz), 2.83Ð2.71 (2H, m), 2.38Ð2.34 (1H, m), 2.14Ð2.06 (1H, m), 1.84Ð1.74 
(2H, m), 1.64Ð1.46 (6H, m), 1.35Ð1.24 (4H, m), 0.90Ð0.83 (1H, m); 
13
C NMR (101 MHz, 
CDCl3) δ = 65.3, 54.8, 44.9, 39.9, 34.2, 29.8, 25.9, 25.3, 25.2, 20.9, 19.7; HRMS (ESI-TOF) 
m/z: [M + H]
+
 Calcd for C11H22NO 184.1701; Found 184.1701; LRMS m/z (ES) 184 (100%, 
MH
+
). For X-ray data, see SI and CCDC 1537946. 
Data for alcohol 6d m.p. 70Ð73 ¡C; νmax/cm
-1
 3250, 2920, 1450; Rf 0.2 [conc. NH3ÐMeOHÐ
CH2Cl2 (1:9:90)]; 
1
H NMR (400 MHz, CDCl3) δ = 4.11 (1H, br t, J 11.0 Hz), 2.91Ð2.74 (2H, 
m), 2.34 (2H, br s), 2.08 (1H, dd, J 14.5, 8.0 Hz), 1.93Ð1.85 (1H, m), 1.83Ð1.69 (4H, m), 
1.68Ð1.57 (5H, m), 1.51Ð1.27 (5H, m); 
13
C NMR (101 MHz, CDCl3) δ = 69.1, 54.5, 43.8, 
40.5, 39.4, 38.0, 37.8, 26.3, 25.8, 22.1, 20.1; HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for 
C11H22NO 184.1701; Found 184.1699; LRMS m/z (ES) 184 (100%, MH
+
). 
Methyl (2E)-11-Chloro-8-oxoundec-2-enoate 7c. To ketone 1c (648 mg, 3.43 mmol) in 
degassed CH2Cl2 (120 mL) was added methyl acrylate (0.70 mL, 6.86 mmol). The mixture 
was heated to 45 ¡C before GrubbsÕ 2
nd
 generation catalyst (71 mg, 0.10 mmol) in CH2Cl2 (20 
mL) was added slowly. After 22 h, the reaction mixture was opened up to air and was allowed 
to cool to room temp. then the solvent was evaporated. Purification by flash column 
chromatography, eluting with EtOAcÐpetrol (1:19 to 1:4), gave the ketone 7c (750 mg, 3.04 
mmol, 89%) as an oil; νmax/cm
-1
 3005, 2930, 1715, 1640; Rf 0.3 [EtOAcÐpetrol (1:4)]; 
1
H 
NMR (400 MHz, CDCl3) δ = 6.97 (1H, dt, J 15.5, 7.0 Hz), 5.87 (1H, dt, J 15.5, 1.5 Hz), 3.75 
(3H, s), 3.60 (2H, t, J 7.0 Hz), 2.62 (2H, t, J 7.0 Hz), 2.46 (2H, t, J 7.0 Hz), 2.27 (2H, qd, J 
7.0, 1.5 Hz), 2.10 (2H, quin, J 7.0 Hz), 1.67 (2H, quin, J 7.0 Hz), 1.51 (2H, quin, J 7.0 Hz); 
13
C NMR (101 MHz, CDCl3) δ = 209.4, 167.0, 148.9, 121.2, 51.4, 44.5, 42.5, 39.2, 31.9, 
27.5, 26.2, 23.1; HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for C12H19O3
35
ClNa 269.0920; 
Found 269.0909; LRMS m/z (ES) 271 (30%, MNa
+
 for 
37
Cl), 269 (100%, MNa
+ 
for 
35
Cl). 
Methyl (2E)-12-Chloro-8-oxododec-2-enoate 7d. To ketone 1d (495 mg, 2.44 mmol) in 
degassed CH2Cl2 (90 mL) was added methyl acrylate (0.45 mL, 4.88 mmol). The mixture was 
heated to 45 ¡C before GrubbsÕ 2
nd
 generation catalyst (62 mg, 0.07 mmol) in CH2Cl2 (15 
mL) was added slowly. After 22 h, the reaction mixture was opened up to air and was allowed 
to cool to room temp. then the solvent was evaporated. Purification by flash column 
chromatography, eluting with EtOAcÐpetrol (1:19 to 1:4), gave the ketone 7d (561 mg, 2.15 
mmol, 88%) as an oil; νmax/cm
-1
 3055, 2990, 1715, 1660; Rf 0.3 [EtOAcÐpetrol (1:4)]; 
1
H 
NMR (400 MHz, CDCl3) δ = 6.97 (1H, dt, J 15.5, 7.0 Hz), 5.86 (1H, dt, J 15.5, 1.5 Hz), 3.75 
(3H, s), 3.56 (2H, t, J 6.5 Hz), 2.48Ð2.42 (4H, m), 2.24 (2H, qd, J 7.0, 1.5 Hz), 1.83Ð1.72 
(4H, m), 1.66Ð1.60 (2H, m), 1.51Ð1.44 (2H, m); 
13
C NMR (101 MHz, CDCl3) δ = 210.0, 
167.0, 148.9, 121.2, 51.4, 44.6, 42.3, 41.7, 2 × 31.9, 27.5, 23.1, 21.0; HRMS (ESI-TOF) m/z: 
[M + Na]
+
 Calcd for C13H21O3
35
ClNa 283.1077; Found 283.1067; LRMS m/z (ES) 285 (30%, 
MNa
+
 for 
37
Cl), 283 (100%, MNa
+ 
for 
35
Cl). 
Methyl (1RS,7RS,8RS)-6-Oxa-5-azatricyclo[6.4.0.0
1,5
]dodecane-7-carboxylate 8c. To ketone 
7c (109 mg, 0.44 mmol) in toluene (5 mL) was added hydroxylamine hydrochloride (67 mg, 
0.97 mmol) and diisopropylethylamine (0.18 mL, 1.06 mmol) and the mixture was heated to 
110 ¡C. After 16 h, the reaction mixture was allowed to cool to room temp. and the solvent 
was evaporated. Purification by flash column chromatography, eluting with MeOHÐCH2Cl2 
(0.5:99.5 to 1:99), gave the cycloadduct 8c (57 mg, 0.25 mmol, 57%) as an oil; νmax/cm
-1
 
2950, 1730, 1435; Rf 0.6 [MeOHÐCH2Cl2 (5:95)]; 
1
H NMR (400 MHz, CDCl3) δ = 4.44 (1H, 
d, J 9.5 Hz), 3.79 (3H, s), 3.35Ð3.31 (2H, m), 2.61Ð2.57 (1H, m), 2.07Ð1.81 (4H, m), 1.77Ð
1.42 (7H, m), 1.33Ð1.22 (1H, m); 
13
C NMR (101 MHz, CDCl3) δ = 172.9, 81.4, 72.6, 54.7, 
52.3, 50.0, 33.8, 32.9, 23.9, 22.9, 21.4, 21.1; HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for 
C12H20NO3 226.1438; Found 226.1441; LRMS m/z (ES) 226 (100%, MH
+
). 
Methyl (1RS,8RS,9RS)-7-Oxa-6-azatricyclo[7.4.0.0
1,6
]tridecane-8-carboxylate 8d. To ketone 
7d (414 mg, 1.59 mmol) in toluene (16 mL) was added hydroxylamine hydrochloride (243 
mg, 3.5 mmol), diisopropylethylamine (0.66 mL, 3.8 mmol) and tetra-n-butylammonium 
iodide (60 mg, 0.16 mmol) and the mixture was heated to 110 ¡C. After 16 h, the reaction 
mixture was allowed to cool to room temp. and the solvent was evaporated. Purification by 
flash column chromatography, eluting with MeOHÐCH2Cl2 (0.5:99.5 to 1:99), gave the 
cycloadduct 8d (184 mg, 0.77 mmol, 48%) as an oil; νmax/cm
-1
 2935, 1750, 1450; Rf 0.6 
[MeOHÐCH2Cl2 (5:95)]; 
1
H NMR (400 MHz, CDCl3) δ = 4.45 (1H, d, J 9.5 Hz), 3.80 (3H, s), 
3.30Ð3.28 (1H, m), 3.00Ð2.94 (1H, m), 2.90Ð2.88 (1H, m), 2.24Ð2.20 (1H, m), 1.98Ð1.93 (1H, 
m), 1.87Ð1.79 (1H, m), 1.75Ð1.72 (1H, m), 1.67Ð1.29 (10H, m); 
13
C NMR (101 MHz, CDCl3) 
δ = 173.9, 79.2, 64.3, 52.3, 52.1, 44.4, 35.5, 30.6, 24.8, 22.7, 21.7, 20.5, 19.5; HRMS (ESI-
TOF) m/z: [M + H]
+
 Calcd for C13H22NO3 240.1594; Found 240.1598; LRMS m/z (ES) 240 
(100%, MH
+
). 
(5RS,10aRS,10bRS)-5-Hydroxy-octahydro-1H-cyclohexa[h]pyrrolizin-6-one 9c. Zinc powder 
(286 mg, 4.37 mmol) was added to cycloadduct 8c (234 mg, 1.04 mmol) in AcOH/H2O (5 
mL, 1:2), and the mixture was heated to 70 ¡C. After 2 h, before being allowed to cool to 
room temp., the zinc salts were filtered, washing the filtrate with CH2Cl2 (20 mL), and the 
solvent was evaporated. The residue was partitioned between aqueous ammonia (18 M, 10 
mL) and CH2Cl2 (20 mL) and was separated. The aqueous layer was extracted with CH2Cl2 (3 
× 20 mL), and the combined organic layers were dried (MgSO4), filtered, and the solvent was 
evaporated. The crude solid was left to stand at rt for 17 h then purification by  flash column 
chromatography, eluting with MeOHÐCH2Cl2 (5:95), give the alcohol 9c (172 mg, 0.88 
mmol, 85%) as an amorphous solid; m.p. 170Ð172 
o
C; νmax/cm
-1
 3245, 2920, 1665; Rf 0.4 
[MeOHÐCH2Cl2 (5:95)]; 
1
H NMR (400 MHz, CDCl3) δ = 5.31 (1H, d, J 4.5 Hz), 4.37 (1H, 
dd, J 6.5, 4.5 Hz), 3.56Ð3.49 (1H, m), 3.22Ð3.16 (1H, m), 2.28Ð2.08 (2H, m), 2.05Ð1.93 (3H, 
m), 1.82Ð1.52 (6H, m), 1.41Ð1.34 (1H, m), 1.26Ð1.13 (1H, m); 
13
C NMR (101 MHz, CDCl3) 
δ = 174.4, 79.4, 69.8, 45.3, 40.1, 35.2, 34.8, 25.8, 23.3, 23.2, 22.4; HRMS (ESI-TOF) m/z: [M 
+ H]
+
 Calcd for C11H18NO2 196.1332; Found 196.1334; LRMS m/z (ES) 196 (100%, MH
+
). 
(7RS,7aRS,11aRS)-7-Hydroxy-decahydropyrido[2,1-r269234]indol-6-one 9d. Zinc powder 
(409 mg, 6.26 mmol) was added to cycloadduct 8d (356 mg, 1.49 mmol) in AcOH/H2O (10 
mL, 1:2), and the mixture was heated to 70 ¡C. After 2 h, before being allowed to cool to 
room temp., the zinc salts were filtered, washing the filtrate with CH2Cl2 (20 mL), and the 
solvent was evaporated. The residue was partitioned between aqueous ammonia (18 M, 10 
mL) and CH2Cl2 (20 mL) and was separated. The aqueous layer was extracted with CH2Cl2 (3 
× 20 mL), and the combined organic layers were dried (MgSO4), filtered, and the solvent was 
evaporated to give the alcohol 9d (237 mg, 1.13 mmol, 76%) as an amorphous solid; m.p. 
163Ð165 ¡C; νmax/cm
-1
 3300, 2910, 1660; Rf 0.4 [MeOHÐCH2Cl2 (5:95)]; 
1
H NMR (400 MHz, 
CDCl3) δ = 4.31 (1H, dd, J 7.5, 2.5 Hz), 3.99 (1H, dd, J 13.0, 4.5 Hz), 2.84 (1H, dt, J 13.0, 
3.0 Hz), 2.74 (1H, d, J 2.5 Hz), 2.01Ð1.90 (3H, m), 1.77Ð1.67 (7H, m), 1.56Ð1.44 (2H, m), 
1.40Ð1.22 (3H, m); 
13
C NMR (101 MHz, CDCl3) δ = 174.1, 73.1, 59.8, 44.2, 37.0, 34.0, 30.2, 
24.7, 23.4, 22.0, 21.3, 19.7; HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C12H20NO2 210.1489; 
Found 210.1490; LRMS m/z (ES) 210 (100%, MH
+
). For X-ray data, see SI and CCDC 
1537947. 
5-Chloro-1-[di(prop-2-en-1-yl)amino]pentan-2-one 11. To 5-chloro-2-pentanone 10 (2.0 mL, 
16.5 mmol) in methanol (20 mL) was added bromine (0.80 mL, 16 mmol) slowly at Ð10 ¡C. 
The mixture was stirred at Ð10 ¡C for 1 h, then at room temp. for 1 h. Water (10 mL) and 
sulphuric acid (18 M, 10 mL) were added and the mixture was stirred at room temp. for 17 h. 
The mixture was diluted with water (20 mL) and was extracted with Et2O (3 × 30 mL). The 
combined organic layers were washed with 10% aqueous solution NaHCO3 (30 mL), water 
(30 mL), then dried (MgSO4), filtered, and the solvent was evaporated to give 1-bromo-5-
chloro-2-pentanone (3.61 g, 18.1 mmol) as an oil (used without further purification). To this 
bromide (3.61 g, 18.1 mmol) in acetonitrile (60 mL) was added diallylamine (2.25 mL, 18.1 
mmol) and potassium carbonate (3.75 g, 27.1 mmol) at room temp. After 17 h, the reaction 
mixture was diluted with 10% aqueous NaHCO3 (15 mL) and water (15 mL) and was 
extracted with EtOAc (3 × 30 mL). The combined organic layers were dried (MgSO4), 
filtered, and the solvent was evaporated. Purification by flash column chromatography, 
eluting with EtOAcÐpetrol (1:9 to 1:4), gave the ketone 11 (2.98 g, 13.8 mmol, 76%) as an 
oil; νmax/cm
-1 
2815, 1715, 1645; Rf 0.4 [EtOAcÐpetrol (2:8)]; 
1
H NMR (400 MHz, CDCl3) δ = 
5.88Ð5.76 (2H, m), 5.19Ð5.13 (4H, m), 3.55 (2H, t, J 6.5 Hz), 3.24 (2H, s), 3.13 (4H, d, J 6.5 
Hz), 2.62 (2H, t, J 6.5 Hz), 2.02 (2H, quin, J 6.5 Hz); 
13
C NMR (101 MHz, CDCl3) δ = 209.4, 
135.0, 118.4, 62.6, 57.8, 44.5, 36.9, 26.2; HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for 
C11H19NO
35
Cl 216.1155; Found 216.1165; LRMS m/z (ES) 218 (35%, MH
+
 for 
37
Cl), 216 
(100%, MH
+
 for 
35
Cl). 
(1RS, 5RS)-3-(Prop-2-en-1-yl)-7-oxa-3,8-diazatricyclo[6.3.0.0
1
,
5
]undecane 12. To 
aminoketone 11 (590 mg, 2.74 mmol) in toluene (30 mL) was added hydroxylamine 
hydrochloride (285 mg, 4.11 mmol) and the mixture was heated at 90 ¡C for 18 h. Following 
this, water (10 mL) and NaOH (1 M, 10 mL) were added. The mixture was extracted with 
CH2Cl2 (4 × 15 mL), dried (MgSO4) and the solvent was evaporated. Purification by flash 
column chromatography, eluting with NH3ÐMeOHÐCH2Cl2 (1:2:97), gave cycloadduct 12 
(220 mg, 41%) as an oil; νmax/cm
-1
 3080, 2955, 2785, 1135, 1025; Rf 0.37 [NH3ÐMeOHÐ
CH2Cl2 (1:2:97)]; 
1
H NMR (400 MHz, CDCl3) δ = 5.96Ð5.86 (1H, m), 5.20Ð5.05 (2H, m), 
4.04 (1H, t, J  8 Hz), 3.60 (1H, dd, J 8 and 6 Hz), 3.27Ð3.21 (1H, m), 3.15Ð3.10 (1H, m), 
3.03Ð2.98 (1H, m), 2.97Ð2.92 (1H, m), 2.87Ð2.85 (1H, m), 2.69Ð2.61 (m, 2H),  2.51Ð2.47 (m, 
1H), 2.32Ð2.29 (1H, m), 2.05Ð1.90 (2H, m), 1.80Ð1.67 (2H, m); 
13
C NMR (101 MHz, CDCl3) 
δ = 135.8, 116.8, 81.8, 71.3, 65.4, 58.5, 58.0, 56.1, 55.7, 36.4, 24.4; HRMS (ESI-TOF) m/z: 
[M + H]
+
 Calcd for C11H18N2O 195.1492; Found 195.1496; LRMS m/z (ES) 195 (100%, 
MH
+
). 
[(5RS, 9RS)-7-(Prop-2-en-1-yl)-1,7-diazaspiro[4.4]nonan-9-yl]methanol 13. To a solution of 
cycloadduct 12 (280 mg, 1.44 mmol) in AcOH/H2O (1:2, 15 mL) was added Zn dust (396 mg, 
6.05 mmol) and the mixture was heated at 70 ¡C for 5 h. Before being allowed to cool, the 
zinc salts were removed by filtration, washing with CH2Cl2 and the solvent was evaporated. 
The residue was partitioned between aqueous ammonia solution (18 M, 5 mL) and CH2Cl2 
(10 mL), the aqueous layer was extracted with CH2Cl2 (2 × 10 mL) and the solvent was 
evaporated to give the alcohol 13 (223 mg, 1.14 mmol, 79%) as an oil; νmax/cm
-1
 3300, 2955, 
1645; Rf 0.39 [NH3-MeOH-CH2Cl2 (1:9:90)]; 
1
H NMR (400 MHz, CDCl3) 5.91Ð5.80 (1H, 
m), 5.19Ð5.06 (2H, m), 3.94Ð3.44 (4H, m), 3.14Ð3.04 (2H, m), 3.02Ð2.87 (2H, m) 2.71Ð2.67 
(1H, m), 2.58Ð2.50 (2H, m), 2.43Ð2.41 (1H, m), 2.10Ð2.03 (1H, m), 1.88Ð1.64 (4H, m);
 13
C 
NMR (101 MHz, CDCl3) 135.6, 116.9, 70.3, 67.0, 62.6, 59.1, 55.2, 47.0, 45.9, 38.0, 25.4; 
HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C11H21N2O 197.1654; Found 197.1649; LRMS 
m/z (ES) 197 (100%, MH
+
). 
Benzyl (5-Chloro-2-oxopentyl)prop-2-en-1-ylcarbamate 14. To ketone 11 (2.39 g, 11.1 
mmol) in toluene (50 mL) was added benzyl chloroformate (4.75 mL, 33.3 mmol) and the 
mixture was heated to 110 ¡C. After 17 h, the reaction mixture was allowed to cool to room 
temp. and the solvent was evaporated. Purification by flash column chromatography, eluting 
with EtOAcÐpetrol (1:9 to 1:4), gave the ketone 14 (2.53 g, 8.17 mmol, 74%) as an oil; 
νmax/cm
-1
 3024, 2955, 1735, 1695; Rf 0.4 [EtOAcÐpetrol (1:4)]; 
1
H NMR (400 MHz, CDCl3, 
rotamers) δ = 7.37Ð7.28 (5H, m), 5.84Ð5.75 (1H, m), 5.19Ð5.11 (4H, m), 4.06 (1H, s), 4.01Ð
3.96 (3H, m), 3.57 (1H, t, J 6.5 Hz), 3.46 (1H, t, J 6.5 Hz), 2.62 (1H, t, J 6.5 Hz), 2.48 (1H, t, 
J 6.5 Hz), 2.07 (1H, quin, J 6.5 Hz), 1.95 (1H, quin, J 6.5 Hz); 
13
C NMR (101 MHz, CDCl3, 
rotamers) δ = 205.0, 156.3 & 155.8, 136.5 & 136.3, 133.3 & 133.2, 128.5, 128.1 & 128.0, 
127.7, 118.1 & 117.5, 67.6, 55.7 & 55.2, 51.2 & 50.7, 44.3 & 44.1, 36.4 & 36.2, 26.1 & 26.0; 
HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C16H21NO3
35
Cl 310.1204; Found 310.1208; 
LRMS m/z (ESI) 312 (35%, MH
+
 for 
37
Cl), 310 (100%, MH
+
 for 
35
Cl). 
Benzyl (1RS,8SR)-6-Oxa-5-azatricyclo[6.3.0.0
1,5
]undecane-10-carboxylate 15. To ketone 14 
(1.10 g, 3.54 mmol) in toluene (40 mL) was added hydroxylamine hydrochloride (369 mg, 
5.31 mmol) and diisopropylethylamine (1.85 mL, 10.62 mmol) and the mixture was heated to 
110 ¡C. After 17 h, the reaction mixture was allowed to cool to room temp. and the solvent 
was evaporated. Purification by flash column chromatography, eluting with MeOHÐCH2Cl2 
(0.5:99.5 to 1.5:98.5), gave the cycloadduct 15 (957 mg, 3.32 mmol, 94%) as an oil; νmax/cm
-1
 
3030, 2970, 1690; Rf 0.5 [MeOHÐCH2Cl2 (5:95)]; 
1
H NMR (400 MHz, CDCl3, rotamers) δ = 
7.38Ð7.32 (5H, m), 5.19Ð5.07 (2H, m), 4.16Ð4.12 (1H, m), 3.91 (1H, d, J 11.5 Hz), 3.66Ð3.56 
(1H, m), 3.76Ð3.61 (2H, m), 3.39Ð3.26 (2H, m), 3.09Ð3.07 (1H, br m), 2.87Ð2.86 (1H, m), 
2.08Ð1.95 (2H, m), 1.91Ð1.81 (2H, m); 
13
C NMR (101 MHz, CDCl3, rotamers) δ = 154.6 & 
154.4, 136.7 & 136.6, 128.5 & 128.4, 128.0 & 127.95, 127.9 & 127.8, 82.3 & 81.3, 71.4, 
66.9, 56.5, 54.8 & 54.1, 50.0, 35.3 & 35.1, 25.0; HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for 
C16H21N2O3 289.1547; Found 289.1546; LRMS m/z (ESI) 289 (100%, MH
+
). 
Benzyl (5RS,9RS)-9-(Hydroxymethyl)-1,7-diazaspiro[4.4]nonane-7-carboxylate 16. Zinc 
powder (909 mg, 13.9 mmol) was added to cycloadduct 15 (957 mg, 3.32 mmol) in 
AcOH/H2O (20 mL, 1:2), and the mixture was heated to 70 ¡C. After 2 h, before being 
allowed to cool to room temp., the zinc salts were filtered, washing the filtrate with CH2Cl2 
(40 mL), and the solvent was evaporated. The residue was partitioned between aqueous 
ammonia (18 M, 20 mL) and CH2Cl2 (40 mL) and was separated. The aqueous layer was 
extracted with CH2Cl2 (3 × 40 mL), and the combined organic layers were dried (MgSO4), 
filtered, and the solvent was evaporated to give the alcohol 16 (958 mg, 3.30 mmol, 99%) as 
an oil; νmax/cm
Ð1
 3395, 3010, 2955, 1675; Rf 0.3 [MeOHÐCH2Cl2 (5:95)]; 
1
H NMR (500 MHz, 
CDCl3, rotamers) δ = 7.35Ð7.30 (5H, m), 5.11 (2H, s), 3.83 (1H, dt, J 12.0, 2.5 Hz), 3.75Ð3.37 
(6H, m), 3.29 (1H, dd, J 11.0, 4.5 Hz), 2.97Ð2.92 (2H, m), 2.03Ð1.99 (1H, m), 1.88Ð1.73 (4H, 
m); 
13
C NMR (126 MHz, CDCl3, rotamers) δ = 155.1 & 154.9, 136.7, 128.4, 128.1 & 128.0, 
127.8, 70.2 & 69.5, 66.9, 61.2 & 60.8, 57.8 & 57.2, 47.4 & 46.9, 46.1, 45.9 & 45.3, 35.4 & 
34.6, 25.9; HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C16H23N2O3 291.1703; Found 
291.1702; LRMS m/z (ESI) 291 (100%, MH
+
). 
1-Bromo-6-chlorohexan-3-one 17.
20b
 To ethyl 4-chlorobutyrate (1.00 mL, 7.14 mmol) in Et2O 
(25 mL) was added titanium(IV) isopropoxide (0.25 mL, 0.86 mmol) and EtMgBr (6.1 mL, 
15.7 mmol, 2.6 M) at room temp. After 17 h, the reaction mixture was diluted with saturated 
aqueous ammonium chloride (15 mL) and was extracted with Et2O (3 × 30 mL). The 
combined organic layers were dried (MgSO4), filtered, and the solvent was evaporated to give 
an intermediate cyclopropanol (1.21 g, 9.02 mmol) as an oil (used without further 
purification). To this cyclopropanol (1.21 g, 9.02 mmol) and potassium carbonate (1.50 g, 
10.8 mmol) in CH2Cl2 (30 mL) was added bromine (0.51 mL, 9.9 mmol) slowly at 0 ¡C. After 
1 h, the mixture was diluted with saturated aqueous sodium thiosulfate (10 mL) and water (10 
mL) and was extracted with CH2Cl2 (3 × 30 mL). The combined organic layers were washed 
with saturated aqueous sodium thiosulfate (30 mL), water (30 mL), then dried (MgSO4), 
filtered, and the solvent was evaporated to give the crude product ketone 17 (1.39 g, 6.52 
mmol, 91%) which was used without further purification; Rf 0.4 [EtOAcÐpetrol (1:9)]; 
1
H 
NMR (400 MHz, CDCl3) δ = 3.63Ð3.58 (4H, m), 3.06 (2H, t, J 6.5 Hz), 2.68 (2H, t, J 7.0 Hz), 
2.10 (2H, quin, J 6.5 Hz). Data consistent with that in the literature.
20b
 
6-Chloro-1-[di(prop-2-en-1-yl)amino]hexan-3-one 18. To ketone 17 (1.68 g, 7.87 mmol) in 
EtOAc (40 mL) was added diallylamine (1.0 mL, 7.87 mmol) and triethylamine (1.10 mL, 
7.87 mmol) at room temp. After 17 h, the reaction mixture was diluted with 10% aqueous 
NaHCO3 (15 mL) and water (15 mL) and was extracted with EtOAc (3 × 40 mL). The 
combined organic layers were dried (MgSO4), filtered, and the solvent was evaporated. 
Purification by flash column chromatography, eluting with EtOAcÐpetrol (1:9 to 1:4), gave 
the ketone 18 (1.19 g, 5.18 mmol, 66%) as an oil; νmax/cm
-1 
2815, 1715, 1645; Rf 0.4 [EtOAcÐ
petrol (2:8)]; 
1
H NMR (400 MHz, CDCl3) δ = 5.90Ð5.80 (2H, m), 5.23Ð5.17 (4H, m), 3.59 
(2H, t, J 6.5 Hz), 3.12 (4H, br d, J 6.5 Hz), 2.80 (2H, t, J 7.0 Hz), 2.67Ð2.60 (4H, m), 2.07 
(2H, quin, J 6.5 Hz); 
13
C NMR (101 MHz, CDCl3) δ = 208.9, 135.0, 117.9 , 56.8, 47.9, 44.5, 
40.7, 39.5, 26.2; HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C12H21NO
35
Cl 230.1306; Found 
230.1301; LRMS m/z (ES) 232 (30%, MH
+
 for 
37
Cl), 230 (100%, MH
+ 
for 
35
Cl). 
Methyl (6-Chloro-3-oxohexyl)prop-2-en-1-ylcarbamate 19. To ketone 18 (368 mg, 1.6 mmol) 
in toluene (16 mL) was added methyl chloroformate (0.45 mL, 5.6 mmol) and the mixture 
was heated to 80 ¡C. After 17 h, the reaction mixture was allowed to cool to room temp. and 
the solvent was evaporated. Purification by flash column chromatography, eluting with 
EtOAcÐpetrol (1:9 to 1:4), gave the carbamate 19 (257 mg, 1.04 mmol, 65%) as an oil; 
νmax/cm
-1
 3085, 2960, 1705, 1650; Rf 0.4 [EtOAcÐpetrol (1:4)]; 
1
H NMR (400 MHz, CDCl3, 
rotamers) δ = 5.78 (1H, br m), 5.21Ð5.17 (2H, m), 3.94Ð3.86 (2H, m), 3.72 (3H, br s), 3.60 
(2H, t, J 6.5 Hz), 3.51Ð3.49 (2H, m), 2.77Ð2.71 (2H, m), 2.64 (2H, t, J 6.5 Hz), 2.06 (2H, 
quin, J 6.5 Hz); 
13
C NMR (101 MHz, CDCl3, rotamers) δ = 208.3 &208.0, 156.6, 133.7, 
117.2 & 116.6, 52.7, 50.3, 44.4, 42.5 & 41.9, 41.5 & 41.0, 39.6, 26.1; HRMS (ESI-TOF) m/z: 
[M + H]
+
 Calcd for C11H19NO3
35
Cl 248.1048; Found 248.1048; LRMS m/z (ESI) 250 (35%, 
MH
+
 for 
37
Cl), 248 (100%, MH
+
 for 
35
Cl). 
Methyl (1RS,7RS)-6-Oxa-5,9-diazatricyclo[5.4.1.0
1,5
]dodecane-9-carboxylate 20 and Methyl 
(1RS,8SR)-6-Oxa-5,10-diazatricyclo[6.4.0.0
1,5
]dodecane-10-carboxylate 21. To ketone 19 
(136 mg, 0.55 mmol) in xylene (6 mL) was added hydroxylamine hydrochloride (58 mg, 0.83 
mmol) and diisopropylethylamine (0.30 mL, 1.65 mmol) and the mixture was heated to 140 
¡C. After 17 h, the reaction mixture was allowed to cool to room temp. and the solvent was 
evaporated. Purification by flash column chromatography, eluting with MeOHÐCH2Cl2 (1:99 
to 2:98), gave the cycloadducts 20 and 21 (103 mg, 0.46 mmol, 84%, (3:1)) as an oil; νmax/cm
Ð
1
 2980, 1690; Rf 0.5 [MeOHÐCH2Cl2 (5:95)]; 
1
H NMR (400 MHz, C6D6, rotamers) δ = 4.29 
(0.45H, q, J 4.0 Hz), 4.22Ð4.19 (0.3H, m), 4.17Ð4.12 (0.45H, ddd, J 14.5, 4.0, 1.0 Hz), 4.10Ð
4.06 (0.3H, m), 3.71Ð3.67 (0.45H, m), 3.58Ð3.54 (0.45H, m), 3.50 (0.75H, s), 3.49 (1.35H, s), 
3.45 (0.9H, s), 3.44Ð3.30 (1.5H, m), 3.20Ð3.14 (1.05H, m), 2.97 (0.75H, dd, J 14.5, 7.5 Hz), 
2.68Ð2.57 (1.05H, m), 1.87Ð1.80 (0.45H, m), 1.68Ð1.54 (2.25H, m), 1.47Ð1.18 (5.25H, m), 
1.06Ð0.99 (0.3H, m); 
13
C NMR (101 MHz, C6D6, rotamers) δ = 156.4, 155.8, 78.7 & 78.4, 
71.5, 71.2, 68.7, 56.7 & 56.6, 55.9, 52.0, 51.9, 51.6 & 51.5, 49.0, 43.1, 42.5, 41.7, 40.8 & 
40.5, 39.4 & 39.2, 38.5, 34.2 & 34.1, 32.2, 24.1, 21.3; HRMS (ESI-TOF) m/z: [M + H]
+
 
Calcd for C11H19N2O3 227.1396; Found 227.1396; LRMS m/z (ES) 227 (100%, MH
+
). 
(1RS,7RS)-9-Methyl-6-oxa-5,9-diazatricyclo[5.4.1.0
1,5
]dodecane 22 and (1RS,8SR)-10-
Methyl-6-oxa-5,10-diazatricyclo[6.4.0.0
1,5
]dodecane 23. The mixtures of cycloadducts 20 
and 21 (138 mg, 0.62 mmol) in THF (2 mL) was added slowly to a solution of LiAlH4 (94 
mg, 2.48 mmol) in THF (6 mL). The grey suspension was then heated to 72 ¡C for 17 h. After 
the solution was cooled to room temp., the reaction was quenched with EtOAc (1 mL) and 
was stirred for 1 h. The light grey suspension was filtered through a sintered glass filter, and 
was rinsed with Et2O (40 mL). The filtrate was concentrated to give the amines 22 and 23 (93 
mg, 0.51 mmol, 80%, (3:1)) as as oil; νmax/cm
Ð1
 2990, 1450; Rf 0.3 [MeOHÐCH2Cl2 (5:95)]; 
1
H NMR (400 MHz, CDCl3) δ = 4.40 (0.75H, dd, J 9.0, 4.5 Hz), 3.66 (0.25H, dd, J 7.5, 5.0 
Hz), 3.49Ð3.48 (1H, m), 3.43Ð3.41 (0.25H, m), 3.31Ð3.24 (1H, m), 3.02Ð2.95 (0.75H, m), 
2.82Ð2.77 (0.5H, m), 2.47 (0.25H, dd, J 4.5, 1.5 Hz), 2.44 (0.5H, dd, J 4.5, 1.5 Hz), 2.41Ð2.30 
(2.5H, m), 2.29Ð2.16 (1.25H, m), 2.14 (2.25H, s), 2.09 (0.75H, s), 1.80Ð1.73 (1.5H, m), 1.70Ð
1.49 (3.5H, m), 1.46Ð1.45 (0.75H, m), 1.44Ð1.42 (0.25H, m); 
13
C NMR (101 MHz, CDCl3) δ 
= 79.1, 71.6, 70.5, 70.0, 64.3, 63.3, 56.8, 56.6, 52.8, 52.6, 48.6, 47.3, 46.0, 41.3, 38.7, 37.9, 
34.1, 33.9, 24.4, 21.2; HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C10H19N2O 183.1497; 
Found 183.1505; LRMS m/z (ES) 183 (100%, MH
+
). 
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